Zettascale computing will make a significant difference to many aspects of our healthcare system. It will help researchers and providers to accelerate drug discovery and design advanced diagnostic solutions.
The recent Covid-19 pandemic has shown us just how important new drugs and vaccines are for our survival. But the current state of drug development is a lengthy, expensive process. The pharmaceutical industry is investing in high performance computing, artificial intelligence, cloud computing and big data to reduce the time and cost of developing new drugs.
Further, medical research has become a big data computational problem. With the advanced power of zettascale systems, a whole range of new treatments and technologies, generally called precision medicine or personalised medicine, promises a future in which treatment options for a range of diseases and conditions will be specifically targeted to the individual genome and health condition.